copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
“Durable left ventricular assist devices as a bridge to . . . Improvements in LVAD technology have resulted in improved short- and long-term outcomes, further supporting the use of these devices for a bridge-to-transplant (BTT) indication LVAD utilization as BTT exhibits notable disparities worldwide, mainly due to variations in organ availability, allocation policies, and financial constraints
Changes in Use of Left Ventricular Assist Devices as Bridge . . . These data suggest that the risks and benefits of LVAD implantation as a BTT have changed under the new allocation system and that the appropriate indication for this treatment strategy warrants a re-evaluation
Left Ventricular Assist Device (LVAD): For Physicians | Stony . . . A: We implant the HeartMate II LVAD, manufactured by Thoratec This was the first FDA approved device for both "bridge to transplant" (BTT) and "destination therapy" (DT) Heartware is a new smaller continuous-flow LVAD approved by the FDA in October 2012 for BTT
Myocardial Recovery Using Ventricular Assist Devices: Ventricular assist devices (VADs) have a long history as essential bridges to transplant (BTT) for patients with end-stage congestive heart failure, and more recently as long-term destination therapy for nontransplant candidates 1,2 For transplant candidates, VAD therapy can improve survival post-transplantation 3,4 Hemodynamic unloading and
Vital BTT, US - MapQuest Vital BTT is a wellness center in Meridian, ID that offers a range of services aimed at promoting holistic health and vitality Specializing in various alternative therapies and treatments, Vital BTT provides a tranquil space for individuals seeking to enhance their well-being through natural and integrative approaches
Changing Strategy Between Bridge to Transplant and . . . Left ventricular assist devices (LVADs) have been implanted as bridge to transplantation (BTT), bridge to candidacy (BTC) or destination therapy (DT) on the basis of relative and absolute contraindications to transplantation